Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
It is a randomized, double-blind clinical trial studying Limosilactobacillus reuteri DSM 17938 (10^8 CFU/d and 10^10 CFU/d) or placebo in 46 people with Type 2 diabetes (T2D) on insulin therapy over 12 weeks (1)
Effect of supplementation on glycated haemoglobin (HbA1c) (1)
The results indicated that this supplementation did not significantly impact HbA1c levels, liver steatosis, adiposity, or microbiota composition (1).
The findings suggest that while L. reuteri DSM 17938 supplementation may not broadly affect certain metabolic parameters, it could have specific benef…